Increased stable retroviral gene transfer in early hematopoietic progenitors released from quiescence

Human Gene Therapy

Volumn 7, Issue 2, 1996, Pages 207-213

  Hatzfeld, A ^a,c   Batard, P ^a   Panterne, B ^a   Taieb, F ^b   Hatzfeld, J ^a  

^a CNRS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UPR 9044 CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CYCLE; CELL STIMULATION; COLONY FORMING UNIT GEMM; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; REPORTER GENE; RETROVIRUS; UMBILICAL CORD BLOOD; VIRUS DNA CELL DNA INTERACTION; VIRUS RECOMBINANT;

UNIDENTIFIED RETROVIRUS;

EID: 0030021326     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.2-207     Document Type: Article

References (38)

1. ANDERSON, W.-F. (1992). Human gene therapy. Science 256, 808-813.
2. + cell population and into TF-1 cells: Future prospects in gene therapy. Hum. Gene Ther. 5, 1325-1333.
3. BRANDT, J., BRIDDELL, R.A., SROUR, E.F., LEEMHIUS, T.B., and HOFFMAN, R. (1992). Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. Blood 79, 634-641.
4. BROXMEYER, H., COOPER, S., LU, L., HANGOC, G., ANDERSON, D., COSMAN, D., LYMAN, S., and WILLIAMS, D. (1991). Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood 77, 2142-2149.
5. BROXMEYER, H.E., DOUGLAS, G.W., HANGOC, G., COOPER, S., BARD, J., ENGLISH, D., ARMY, M., THOMAS, L., and BOYSE, E.A. (1989). Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA 86, 3828-3832.
6. BROXMEYER, H.E., HANGOC, G., and COOPER, S. (1992). Clinical and biological aspects of human umbilical cord blood as a source of transplantable hematopoietic stem and progenitor cells. Bone Marrow Transplant. 9, 7-10.
7. BROXMEYER, H.E., HANGOC, G., COOPER, S., RIBEIRO, R.C., GRAVES, V., YODER, M., WAGNER, J., VADHAN-RAJ, S., BENNINGER, L., RUBINSTEIN, P., and BROUN, E.R. (1992). Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc. Natl. Acad. Sci. USA 89, 4109-4113.
8. - human umbilical cord blood cells reveals their potentiality to engraft adults. Proc. Natl. Acad. Sci. USA 90, 8707-8711.
9. CARDOSO, A.A., WATT, S., BATARD, P., LI, M.-L., HATZFELD, A., GENEVIER, H., and HATZFELD, J. (1995). An improved panning technique for the selection of CD34-positive human bone marrow hematopoietic cells with high recovery of early progenitors. Exp. Hematol. 23, 407-412.
10. + bone marrow progenitor cells. Blood 82, 3290-3297.
11. DANIELPOUR, D., DART, L.L., FLANDERS, K.C., ROBERTS, A.B., and SPORN, M.B. (1989). Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell. Physiol. 138, 79-86.
12. DANOS, O., and MULLIGAN, R.C. (1988). Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85, 6460-6464.
13. FAUSER, A.A., and MESSNER, H.A. (1979). Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neutrophilic granulocytes and erythroblasts. Blood 53, 1023-1027.
14. FERRY, N., DUPLESSIS, O., HOUSSIN, D., DANOS, O., and HEARD, J.-M. (1991). Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 88, 8377-8381.
15. GLUCKMAN, E., BROXMEYER, H.E., AUERBACH, A.D., FRIEDMAN, H.S., DOUGLAS, G.W., DEVERGIE, A., ESPEROU, H., THIERRY, D., SOCIE, G., LEHN, P., COOPER, S., ENGLISH, D., KURTZBERG, J., BARD, J., and BOYSE, E.A. (1989). Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 3, 1174-1178.
16. GLUCKMAN, E., DEVERGIE, A., THIERRY, D., EPEROU-BOURDEAU, H., TRAINEAU, R., GERROTA, J., BROSSARD, Y., VAN NIFTERIK, J., and BENBUNAN, M. (1992). Clinical applications of stem cell transfusion from cord blood and rationale for cord blood banking. Bone Marrow Transplant. 9, 114-117.
17. HATZFELD, J., LI, M.-L., BROWN, E.L., SOOKDEO, H., LEVESQUE, J.-P., O'TOOLE, T., GURNEY, C., CLARK, S.C., and HATZFELD, A. (1991). Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 or Rb oligonucleotides. J. Exp. Med. 174, 925-929.
18. HOWS, J.M., BRADLEY, B.A., MARSH, J.C.W., LUFT, T., COUTINHO, L., TESTA, N.G., and DEXTER, T.M. (1992). Growth of human umbilical-cord blood in long term haemopoietic cultures. Lancet 340, 73-76.
19. KARLSSON, S. (1991). Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 78, 2481-2492.
20. LAJTHA, L.G., and SCHOFIELD, R. (1974). On the problem of differentiation in haemopoiesis. Differentiation 2, 313-320.
21. 0 phase of early human hematopoietic progenitors in serum-or serum-free culture. In Blood Cell Growth Factors; Their Present and Future Use in Hematology and Oncology. M.J. Murphy, ed. (AlphaMed Press, Dayton, OH) pp. 228-232.
22. LI, M.-L., CARDOSO, A.A., SANSILVESTRI, P., HATZFELD, A., KISSELEV, S., BATARD, P., LEVESQUE, J.P., and HATZFELD, J. (1993). Co-stimulatory effects of Steel Factor, the c-kit ligand, on purified human hematopoietic progenitors in low cell density culture. Nouv. Rev. Fr. Hematol. 35, 81-86.
23. LI, M.-L., CARDOSO, A.A., SANSILVESTRI, P., HATZFELD, A., BROWN, E.L., SOOKDEO, H., LEVESQUE, J.P., CLARK, S.C., and HATZFELD, J. (1994). Additive effects of steel factor and antisense TGF-β1 oligodeoxynucleotide on CD34+ hematopoietic progenitor cells. Leukemia 8, 441-445.
24. + hematopoietic stem/progenitor cells from human umbilical cord blood. J. Exp. Med. 178, 2089-2096.
25. + cells purified from peripheral blood of breast cancer patients primed with chemotherapy and granulocyte-macrophage colony-stimulating factor. Hum. Gene Ther. 5, 203-208.
26. MACGREGOR, G.R., NOLAN, G.P., FIERING, S., ROEDERER, M., and HERZENBERG, L.A. (1991). Use of E. coli lacZ (β-galactosidase) as a reporter gene. Methods Mol. Biol. 7, 217-235.
27. McNIECE, I., STEWART, F.M., DEACON, D.M., TERMELES, D.S., SZEBO, K.M., CLARK, S.C., and QUESENBERRY, P.J. (1989). Detection of a human CFC with a high proliferative potential. Blood 74, 609-612.
28. McNIECE, I.K., BERTONCELLO, I., KRIEGLER, A.B., and QUESENBERRY, P.J. (1990). Colony-forming cells with high proliferative potential (HPP-CFC). Int. J. Cell Cloning 8, 146-160.
29. McNIECE, I., LANGLEY, K., and ZSEBO, K. (1991). Recombinant human stem cell factor synergises with GM-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp. Hematol. 19, 226-231.
30. MILLER, A.D. (1992). Human gene therapy comes of age. Nature 357, 455-460.
31. MILLER, D.G., ADAM, M.A., and MILLER, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
32. MORGAN, R.A., and ANDERSON, W.F. (1993). Human gene therapy. Annu. Rev. Biochem. 62, 191-217.
33. MORITZ, T., KELLER, D.C., and WILLIAMS, D.A. (1993). Human cord blood cells as targets for gene transfer: Potential use in genetic therapies of severe combined immunodeficiency disease. J. Exp. Med. 178, 529-536.
34. NOLTA, J.A., and KOHN, D.B. (1990). Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum. Gene Ther. 1, 257-268.
35. SANSILVESTRI, P., CARDOSO, A.A., LEVESQUE, J.-P., PANTERNE, B., HATZFELD, A., MONIER, M.-N., BROWN, E.L., and HATZFELD, J. (1995). Endogenous TGF-β down-modulates c-kit and maintains CD34 expression in early human hematopoietic progenitor cells. Blood 86, 1729-1735.
36. STRAIR, R.K., TOWLE, M., and SMITH, B.R. (1990). Retroviral mediated gene transfer into bone marrow progenitor cells: Use of beta-galactosidase as a selectable marker. Nucleic Acids Res. 18, 4759-4762.
37. VARMUS, H.E., PADGETT, T., HEASLEY, S., SIMON, G., and BISHOP, J.M. (1977). Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell 11, 307-319.
38. ZHOU, Y.-Q., STANLEY, E.R., CLARK, S.C., HATZFELD, J., LEVESQUE, J.-P., FEDERICI, C., WATT, S.M., and HATZFELD, A. (1988). Interleukin-3 and interleukin-1a allow earlier bone marrow progenitors to respond to human colony-stimulating factor 1. Blood 72, 1870-1874.